Nuvation Bio Inc. (NUVB) Misses Q2 EPS by 183c

August 5, 2024 8:04 AM EDT

Nuvation Bio Inc. (NYSE: NUVB) reported Q2 EPS of ($1.89), $1.83 worse than the analyst estimate of ($0.06). Revenue for the quarter came in at $1.44 million.

For earnings history and earnings-related data on Nuvation Bio Inc. (NUVB) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings

Related Entities

Earnings, Maynard Um, Mark Zuckerberg, ARK